What is 'scromiting' and what causes it?

'Scromiting' is a new term for severe nausea, vomiting, and screaming caused by cannabinoid hyperemesis syndrome (CHS), a side effect of prolonged cannabis use. Its exact cause is still being researched.

Is cannabinoid hyperemesis syndrome (CHS) common according to medical experts like Dr. David Streem?

Dr. David Streem of the Cleveland Clinic states that most emergency departments see daily cases of CHS, suggesting it is not rare.

What do marijuana advocates like NORML say about 'scromiting' and CHS?

Advocates like NORML call 'scromiting' sensational and argue that CHS is very rare, suggesting the syndrome is being used as an anti-marijuana talking point.

Home / Health / 'Scromiting': Marijuana's Disturbing New Symptom

'Scromiting': Marijuana's Disturbing New Symptom

9 Dec

•

Summary

A new term, 'scromiting,' describes severe nausea and vomiting from cannabis.
Medical experts warn of cannabinoid hyperemesis syndrome (CHS), while advocates downplay its rarity.
The cause of CHS remains unclear, with debates over cannabis potency and synthetic products.

'Scromiting': Marijuana's Disturbing New Symptom

A new slang term, 'scromiting,' is gaining attention to describe a distressing symptom associated with prolonged cannabis use. This term combines "screaming" and "vomiting," reflecting the intense pain and cyclical vomiting experienced by individuals with cannabinoid hyperemesis syndrome (CHS). Medical experts, such as those at the Cleveland Clinic, report frequent cases and note that conventional anti-nausea medications are often ineffective.

The emergence of 'scromiting' has sparked debate. While some medical professionals view it as a serious warning sign of CHS, marijuana advocates, like those from NORML, dismiss it as sensationalism. They argue that CHS is rare and that the focus on this new term distracts from a lack of comprehensive research into its actual causes.

The exact causes of CHS remain murky, with limited research available. Discussions revolve around daily marijuana use, cannabis potency, and the potential role of unregulated or synthetic cannabis products like Delta-8 and Delta-10. The syndrome was first documented in 2004, and determining its prevalence continues to be a challenge due to inconsistent research findings.